Home / Inspections / 1249226

FDA Inspection 1249226 — Aspire Houston Fertility Institute

Aspire Houston Fertility Institute — FEI 1000543561

The FDA completed an inspection of Aspire Houston Fertility Institute on August 28, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 28, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1117002 (VAI Thu Feb 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041022 (NAI Wed Jan 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014004 (NAI Mon Dec 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 695932 (VAI Mon Nov 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources